We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+8.28%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1.08B
AUM Growth
+$68.1M
Cap. Flow
-$8.47M
Cap. Flow %
-0.78%
Top 10 Hldgs %
46.99%
Holding
55
New
3
Increased
14
Reduced
23
Closed

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$5.95M
2
MMM icon
3M
MMM
+$2.72M
3
ADP icon
Automatic Data Processing
ADP
+$2.58M
4
IBM icon
IBM
IBM
+$2.58M
5
MDT icon
Medtronic
MDT
+$2.56M

Sector Composition

Rank Sector Weight
1 Technology 28.81%
2 Healthcare 20.58%
3 Consumer Staples 18.3%
4 Industrials 14.75%
5 Consumer Discretionary 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
1
Oracle
ORCL
$417B
$61.9M 5.73%
1,377,100
+16,536
+1% +$673K
MSFT icon
2
Microsoft
MSFT
$3.72T
$61.9M 5.73%
1,332,855
-19,625
-1% -$921K
MMM icon
3
3M
MMM
$94.5B
$51.6M 4.78%
375,560
-21,194
-5% -$2.72M
CSCO icon
4
Cisco
CSCO
$475B
$49.6M 4.59%
1,782,250
-9,060
-0.5% -$234K
MDT icon
5
Medtronic
MDT
$115B
$49.4M 4.57%
683,674
-36,875
-5% -$2.56M
WMT icon
6
Walmart Inc
WMT
$896B
$48.6M 4.5%
1,696,404
-8,598
-0.5% -$232K
BDX icon
7
Becton Dickinson
BDX
$49.1B
$48.2M 4.47%
355,308
-5,884
-2% -$753K
PG icon
8
Procter & Gamble
PG
$337B
$48M 4.45%
526,973
-9,012
-2% -$793K
RTX icon
9
RTX Corp
RTX
$301B
$46M 4.26%
636,188
+17,956
+3% +$1.22M
OMC icon
10
Omnicom Group
OMC
$23.6B
$42.2M 3.91%
545,158
-16,725
-3% -$1.22M
CHRW icon
11
C.H. Robinson
CHRW
$17B
$40.2M 3.72%
536,647
+3,270
+0.6% +$233K
AAPL icon
12
Apple
AAPL
$4.47T
$39.8M 3.68%
1,441,896
+57,712
+4% +$1.57M
MCD icon
13
McDonald's
MCD
$193B
$38.5M 3.56%
410,807
-14,931
-4% -$1.4M
KO icon
14
Coca-Cola
KO
$374B
$38.4M 3.56%
909,909
-35,530
-4% -$1.52M
JNJ icon
15
Johnson & Johnson
JNJ
$623B
$34.3M 3.17%
327,570
-4,729
-1% -$498K
ACN icon
16
Accenture
ACN
$109B
$32.9M 3.04%
368,025
+12,464
+4% +$1.03M
VAR
17
DELISTED
Varian Medical Systems, Inc.
VAR
$31.7M 2.94%
418,074
+25,043
+6% +$1.86M
IBM icon
18
IBM
IBM
$225B
$31.2M 2.89%
203,410
-16,210
-7% -$2.58M
NVO
19
Novo Nordisk
NVO
$206B
$30.4M 2.81%
1,435,230
-31,250
-2% -$698K
NKE icon
20
Nike
NKE
$60.8B
$29.6M 2.74%
615,910
-126,868
-17% -$5.95M
BRK.B icon
21
Berkshire Hathaway Class B
BRK.B
$1.11T
$28.4M 2.63%
189,191
-1,897
-1% -$274K
BAX icon
22
Baxter International
BAX
$14.3B
$25.7M 2.38%
645,506
+47,275
+8% +$1.84M
PEP icon
23
PepsiCo
PEP
$188B
$21.8M 2.02%
230,502
+16,554
+8% +$1.59M
SYY icon
24
Sysco
SYY
$40.3B
$21.1M 1.95%
531,339
+46,844
+10% +$1.82M
SYK icon
25
Stryker
SYK
$134B
$20.3M 1.88%
214,910
+9,540
+5% +$846K

Similar funds

Saratoga Research & Investment Management's Q4 2014 Portfolio in Review

As of Q4 2014, Saratoga Research & Investment Management held 55 positions worth $1.08B, up 6.7% from $1.01B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Saratoga Research & Investment Management's Q4 2014 filing shows 3 new, 14 increased and 23 reduced positions. Its largest new stake was Alphabet (Google) Class C: 80,039 shares worth $2.12M. The largest sale was Nike, an estimated $5.95M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Saratoga Research & Investment Management's largest Q4 2014 buy was Alphabet (Google) Class C: 80,039 shares worth $2.12M.
  • Saratoga Research & Investment Management added most to Varian Medical Systems, Inc. in Q4 2014, an estimated $1.86M increase.
  • Saratoga Research & Investment Management's biggest Q4 2014 reduction was Nike, cutting an estimated $5.95M.
  • Saratoga Research & Investment Management's ten largest holdings make up 47% of its $1.08B portfolio in Q4 2014.
  • Saratoga Research & Investment Management opened 3 new positions and closed 0 in Q4 2014.
  • Saratoga Research & Investment Management's portfolio value rose 6.7% quarter-over-quarter to $1.08B.

Based on Saratoga Research & Investment Management's 13F filing for Q4 2014, filed 30 Jan 2015.